Articles
Why Employers Need to Continuously Monitor Their PBM
Many employers may not realize that monitoring their pharmacy benefit manager’s (PBM) performance to contract terms on a regular basis can potentially save money on their Rx benefit. Even after your contract is finalized, it’s vital that you continue to monitor your...
Give your company an Rx plan windfall
Many companies have announced plans to share their tax reform windfall with their employees in the form of raises and/or bonuses. After many years of raises in the 1-2% range, this may be the first time in a decade or more since some workers have seen real wage...
Case Studies
San Diego Electrical Health and Welfare Trust
Read about how we helped the San Diego Electrical Health and Welfare Trust save an overall of 30% on pharmacy benefits in this recent case study.
Recent Newsletters
Effective Prior Authorization Management
Effective Prior Authorization Management August 2023 The effective management of the Prior Authorization (PA) function is a crucial aspect of healthcare that ensures patients receive the appropriate medications while controlling costs. Pharmacy Benefit Managers (PBMs)...
Conflict of Interest
Conflict of Interest July 2023 Recently a respected competitor published an article condemning most pharmacy benefit consultants for not disclosing conflicts of interest. They correctly pointed out that many big corporations such as “Boeing and UPS to local school...
New Transparency Models
New Transparency Models May 23, 2023 Both Express Scripts and OptumRx have announced new, optional Pass-Through pricing programs. Their clients can adopt this new pricing strategy, or they can continue with non-transparent pricing where the PBM won’t disclose the true...
Invokana Pricing slashed via The Mark Cuban Cost Plus Drug Company
Invokana Pricing slashed via The Mark Cuban Cost Plus Drug Company April 2023 The Mark Cuban Cost Plus Drug Company has announced that they have entered into a contract with JanssenUS, a subsidiary of Johnson and Johnson, to distribute Invokana, an important...
Novo Nordisk and Sanofi to cut Insulin prices, following moves by Eli Lilly
Novo Nordisk and Sanofi to cut Insulin prices, following moves by Eli Lilly March 2023Novo Nordisk to cut U.S. list prices for several insulin products by up to 75% next year. Sanofi announced that it will cut prices by 78%. Effective January 1st, 2024. Generally...
Senators introduced bills to reform PBMs and create new FTC probe
Senators introduced bills to reform PBMs and create new FTC probe February 2023 U.S. Senator Cantwell (D-Wash) recently re-introduced the Pharmacy Benefit Manager Transparency Act of 2022 which was previously co-sponsored by herself and Senator Grassley (R-Iowa). The...